
When the Science Isn't There: How Peptide Marketing Claims Are Becoming the DOJ's Easiest Wire Fraud Cases
For peptide vendors, clinics, and telehealth platforms, marketing copy is the evidence federal prosecutors are using to convert FDCA violations into multi-count wire fraud indictments.












